Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute–Designated Cancer Program We distributed a 21-item survey on cancer screening ...
Post-COVID-19, colonoscopy and FIT usage declined, while stool DNA testing increased among privately insured adults. Screening preferences varied by sex, socioeconomic status, and metropolitan versus ...
Adherence with the multitarget stool DNA test for colorectal cancer screening in rural southeastern Kentucky. This is an ASCO Meeting Abstract from the 2022 ASCO Gastrointestinal Cancers Symposium.
Aflac hopes that every time you see a checkered pattern, you’ll be reminded to get checked for cancer. That’s one ambitious aim of the insurer’s new "Check for Cancer" initiative, which Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results